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COMMENTARY Open Access
Male reproductive health statement (XIIIth
international symposium on Spermatology,
may 9th–12th 2018, Stockholm, Sweden
Hagai Levine1, Hideo Mohri2, Anders Ekbom3, Liliana Ramos4, Geoff Parker5, Eduardo Roldan6, Luca Jovine7,
Sabine Koelle8, Anna Lindstrand9, Simone Immler10, Sharon Mortimer11,12, David Mortimer11,13,
Gerhard van der Horst14, Sumio Ishijima15, Natalie Aneck-Hahn16, Elisabetta Baldi17, Roelof Menkveld18,
Susan A Rothmann19, Aleksander Giwercman20, Yvonne Giwercman20, Mats Holmberg21, Ulrik Kvist21,
Lars Björndahl21, Rebecka Holmberg21, Stefan Arver21, John Flanagan21 and Joël R Drevet22*
Abstract
On the occasion of the XIIIth International Symposium on Spermatology held from 9 to 13 May 2018 in Stockholm
(Sweden), participants (guest speakers and audience) collectively felt the need to make a public statement on the
general issue of male reproductive health. Our intention is to raise awareness of what we believe is a neglected area of
research despite alarming situations around the world. The disclosure strategy desired by the co-authors is to bring it
to the attention of the greatest number partly by considering co-publication in the various periodicals dealing with
Reproductive Biology and Andrology. BaCA’s editorial office accepted this mission and found it natural that our
periodical, the official journal of the French Andrology Society (SALF), should carry this message.
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Résumé
A l’occasion du XIIIeme Symposium international sur la Spermatologie qui s’est. tenu du 9 au 13 Mai 2018 à
Stockholm (Suède), les participants (orateurs invités et l’auditoire) ont ressenti collectivement le besoin de faire une
déclaration publique sur la question générale de la santé reproductive masculine. Notre intention est. de mieux
faire connaître ce que nous pensons être un domaine de recherche négligé malgré des situations alarmantes dans
le monde entier. La stratégie de divulgation souhaitée par les co-auteurs est. de le porter à l’attention du plus
grand nombre en envisageant pour partie une co-publication dans les différents périodiques traitant de
Reproduction et d’Andrologie. Le bureau éditorial de BaCA, a accepté cette mission et a trouvé naturel que notre
périodique, journal officiel de la Société d’Andrologie en Langue Française (SALF) porte ce message.
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We, scientists, public health professionals and clinicians
working in spermatology, are calling on governments,
organizations, the scientific and medical communities,
and individuals to acknowledge the importance of
male reproductive health for the survival of the hu-
man and other species, to increase efforts and re-
sources allocated to studying the causes of disruption
of male reproductive health, and to implement pol-
icies to remove hazards to, and promote optimal envi-
ronments for, male health and reproduction.
Fertility, both female and male, and reproductive func-
tion in general are essential for the health and survival of
our species. Now there is growing evidence of the effect of
the male’s age and health on the offspring, that testis func-
tion is an important marker of a man’s health, and that his
semen quality is a strong indicator of his future health.
Given that the sperm cell has unique qualities and a
highly specific biological function, the field of spermatol-
ogy continues to be a significant resource for enhancing
our understanding of the most fundamental biological
processes and the impact of the environment on the for-
mation of life itself. This has potential broad implica-
tions for humans and humanity.
Until now, the field of male reproduction research has
been surprisingly neglected, possibly due to cultural biases,
wrongly considering reproduction to be mainly a female
issue. In addition, the successful and widespread introduc-
tion of assisted reproductive technologies to circumvent
even severe male factor infertility has lessened motivation
to sustain research in this field as these technologies are
considered to be the “remedy” for almost all causes of male
infertility. However, we currently know very little about any
possible long-term consequences, and so it is critical to
continue research to further improve these clinical tech-
nologies and not succumb to short-cutting strategies.
A recent meta-analysis reported a steep decline in human
sperm counts over the last 40 years. This decline is a source
of great concern, particularly when considered alongside re-
ports of other adverse male reproductive health trends in
human and animal populations, and specific studies on
hazards to male reproductive development and function.
Against this background we call on:
Governments and organizations to: acknowledge de-
creased male fertility as a major public health problem
and to recognize the importance of male reproductive
health for the survival of the human and other species;
increase efforts and resources allocated to studying the
causes of disruption of male reproduction; introduce re-
productive health surveillance systems; and implement
policies to prevent exposure to hazards to male fertility
and ensure optimal environments for male reproductive
health. Proper health promotion and education pro-
grams aimed at improving the reproductive health of
populations and individuals, with specific emphasis on
recognizing the crucial contribution of both sexes, are
critical. There also needs to be strengthened regulatory
requirements regarding the effect of pharmaceuticals on
sperm function.
The scientific and medical community to work to-
gether to develop a global and local research agenda tar-
geted at understanding the causes and implications of
disruption of male reproductive health, and to encourage
interdisciplinary research, taking one health approach
and considering the developmental origin of health and
diseases. We should train scientists and clinicians at all
levels in andrology and in recognizing the crucial contri-
bution of both sexes to reproduction.
Individuals (public) to understand that male repro-
ductive health is critical for fecundity, that it can be
evaluated, and that each man’s environment and life
choices can affect his sperm quantity, quality and func-
tion, which can reflect his future health. Raising aware-
ness may enable men to make preventive life choices
and request adequate medical assessment as a part of in-
fertility investigation.
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